Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Get CLEATUSFree Trial

Get CLEATUSFree Trial

Search

Top

Back to Contracts

Typhoid Vaccine Supply and Packaging

Active

Federal

Response Deadline08/04/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

General Info

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

FPO, AP, 96691-3300, US

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedJul 29

subcontract

Response DeadlineAug 4

Submission deadline

Response Deadline

08/04/2026, 05:00:00 PM UTCin 5 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Supply of 10 mL vials containing Typhoid Vi Polysaccharide Vaccine, modified, acellular formulation, with compliant labeling, packaging, and hazardous materials documentation.

Similar Contracts

Same NAICS industry code

Pharmaceutical Tablet Supply – Sumatriptan Succinate 25mg

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Benzoic Tincture, Compound, USP (NSN: 6505016549628)

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and Supply – Benzonatate Capsules

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Silver Nitrate Applicators for Military Medical UseThe contract entails the manufacture and supply of sterile, individually packaged silver nitrate applicators compliant with stringent military medical standards, intended for use by U.S. Department of Defense medical personnel. These applicators must meet precise quality and safety requirements to ensure reliable performance in field and clinical settings, with delivery directed to DLA Troop Support facilities at Joint Base Pearl Harbor-Hickam, identified by zip code 96853-5256. The solicitation, categorized as a subcontract under NAICS code 325412, is issued by the Medical Supply Chain Pharm FSA under the Department of Defense and requires responses by August 3, 2026. All products must be packaged individually and meet the regulatory, sterilization, and labeling specifications dictated by military medical procurement guidelines to guarantee compatibility and safety in operational environments.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Pharmaceutical Manufacturing and Supply – Albuterol Sulfate Inhalation Aerosol

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

NORETHINDRONE AND E

Solicitation # SPE2DP-26-T-4362

The contract pertains to the procurement of 1 mg norethindrone and 0.035 mg ethinyl estradiol tablets in a 28-tablet cycle format, with six cycles per package totaling 168 tablets per unit, designated as a single package unit of issue. The product must comply with stringent technical and quality requirements outlined in the DLA Master List of Technical and Quality Requirements, including adherence to the Medical Marking Standard No. 1 dated February 4, 2013, which supersedes MIL-STD-129. Shelf life is strictly limited to 36 months with no extensions permitted, and storage must be maintained at 20–25°C (68–77°F) as per USP controlled room temperature standards. Labeling must include the NSN, manufacturer, CAGE code, date of manufacture, expiration date, contract number, and lot number. Packaging must be commercial-grade, sealed to prevent damage or breakage, and shipped in suitable exterior containers to ensure safe, cost-effective delivery to the destination point under FOB destination terms. The item is manufactured by Teva Pharmaceuticals USA, Inc., with NDC 00555-9010-58, and is identified by NSN 6505-01-365-2363. Delivery is required within 20 days, with zero tolerance for variance in quantity, and inspection and acceptance occur at the destination. The solicitation is issued under contract number SPE2DP-26-T-4362, with a response deadline of August 4, 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Timothy McCauley listed as the primary point of contact.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4366

The contract specifies the procurement of MULTIPLE ELECTROLYTES INJECTION, TYPE 1, USP, in 1000 mL plastic bags, containing 14 units per case, with a pharmaceutical pH of 7.4. The product is manufactured by BAXTER HEALTHCARE CORPORATION under part number 2B2544X and is regulated by the FDA. It must be stored at room temperature, 25°C (77°F), with avoidance of excessive heat, and kept tightly closed in a cool, well-ventilated environment. The item has a non-extendable shelf life of 18 months as governed by RS001 for TYPE I (CODE K) classification and must be marked in accordance with the latest Medical Marking Standard No. 1. Packaging must comply with MIL-STD-2073-1E and the DLA packaging requirements, with latex-free plastic containers. The NSN is 6505014625492, and the unit of issue is PG, with a single unit ordered. Delivery is required within 20 days FOB destination, with zero tolerance for quantity variance and inspection and acceptance occurring at the destination. The solicitation number is SPE2DP-26-T-4366, issued by the Department of Defense’s Medical Supply Chain PHARM FSA with performance at Fort Bragg, North Carolina. Technical and quality requirements referenced under R numbers are governed by the DLA Master List of Technical and Quality Requirements, with revision control tied to the solicitation issue date. The contracting official must submit an EBS referral for FDA-regulated product confirmation, including bidder and manufacturer details. The contract was posted July 29, 2026, with a response deadline of August 4, 2026, under NAICS code 325412 for pharmaceutical preparation manufacturing.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ZINC OXIDE OINTMENT

Solicitation # SPE2DP-26-T-4364

The contract specifies the procurement of Zinc Oxide Ointment USP, a topical skin protectant containing 20% zinc oxide, supplied in collapsible tubes of 28.35 grams per unit, designated as a tube (TU). The product must be stored at controlled room temperature not exceeding 30°C (86°F) and has a non-extendable shelf life of 36 months as a Type I (Code Q) item. Packaging and labeling must strictly comply with MIL-STD-129 and the latest Medical Marking Standard No. 1, with all packaging requirements governed by the DLA Master List of Technical and Quality Requirements, which override ASTM D3951. The item is regulated by the FDA, requiring buyer referral for confirmation, and must be shipped via traceable means, excluding parcel post. All shipments are FOB destination with no quantity variance allowed, and inspection and acceptance occur at the delivery point. The item is identified by NSN 6505001501990 and manufacturer part number NDC67777-0223-11 from Dynarex Corp. Deliveries are split across six CLINs totaling 30 tubes, with delivery dates ranging from July 15 to July 30, 2026, directed to various military and government installations across the United States. Each delivery location has specific freight and marking instructions, including traceable carrier details and contract identifiers, and all must adhere to DLA packaging and palletization standards under RP001. The contract number is SPE2DP-26-T-4364 and the unit price is $3.00 per tube for all line items.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BENZONATATE CAPSULES

Solicitation # SPE2DP-26-T-4357

BENZONATATE CAPSULES, USP, 100 MG, are supplied in bottles of 100 capsules each, with the active ingredient being 100 milligrams of benzonatate per capsule. The product must be stored at controlled room temperature between 20°C and 25°C (68°F to 77°F) and protected from light, moisture, and humidity. This item falls under a Type I (Code Q) shelf-life classification with a non-extendable shelf life of 36 months and must be marked in accordance with the latest edition of Medical Marking Standard No. 1. It is regulated by the FDA, and buyers are required to submit a referral via EBS to the product specialist, including bidder and manufacturer details such as names, part numbers, and NDC codes. The item is subject to DLA packaging requirements and technical quality standards referenced in the DLA Master List of Technical and Quality Requirements. The contract specifies delivery of four bottles under purchase request 7017663196, with delivery due within 20 days FOB destination, no variance allowed in quantity, and inspection and acceptance occurring at the destination. The NSN is 6505-00-660-1798, and the solicitation number is SPE2DP-26-T-4357, issued by the Department of Defense’s Medical Supply Chain PHARM FSA, with a response deadline of August 4, 2026. Primary point of contact is Imerah Burnett, and packaging must comply with MIL-STD-2073-1E.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TRICHLOROACETIC ACID

Solicitation # SPE2DP-26-T-4354

The contract specifies the procurement of Trichloroacetic Acid, ACS grade, 80% concentration, in 15 mL units, identified by NSN 6505-01-363-7674 and part number 749887 from AmerisourceBergen Drug Corp. The item is classified as a TYPE I (CODE M) with a non-extendable shelf life of 24 months and must be packaged and marked in full compliance with Medical Marking Standard No. 1, superseding MIL-STD-129. Packaging must meet commercial standards with sealed unit containers and shipping containers capable of preventing damage during transit, ensuring safe delivery by common carrier at the lowest cost to the designated destination in APO, 09094-3219. The item is regulated by the FDA, requiring referral through EBS for confirmation, and delivery must occur within 20 days FOB destination with zero quantity variance allowed. Inspection and acceptance occur at the delivery point. Suppliers must provide Safety Data Sheets (SDS) and labels compliant with OSHA’s revised Hazard Communication Standard (29 C.F.R. 1910.1200), effective June 1, 2015, and must train employees on these requirements. All documentation must align with DLA’s Master List of Technical and Quality Requirements, and the unit of issue is BT, equivalent to 15 mL. The contract is issued under SPE2DP-26-T-4354, with a response deadline of August 4, 2026, and is governed by federal procurement regulations including DLA packaging and hazardous material handling standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

DIBUCAINE OINTMENT

Solicitation # SPE2DP-26-T-4358

Dibucaine Ointment USP is a topical pharmaceutical product containing one percent dibucaine as the active ingredient, specifically formulated for rectal administration and external use only. It is supplied in a collapsible tube and a rectal applicator, with each unit of issue being a single package containing one ounce or 28 grams of the ointment. Storage requirements mandate a temperature range of 15 to 30 degrees Celsius (59 to 86 degrees Fahrenheit). The product is regulated by the FDA and must be marked in accordance with the latest edition of Medical Marking Standard No. 1, with a non-extendable shelf life of 36 months as a Type I (Code Q) item. Packaging must comply with MIL-STD-2073-1E, and government identification must be removed from any non-accepted supplies. The contract specifies a procurement quantity of two packages, to be delivered FOB destination within 20 days, with zero variance allowed in quantity. The item is identified by NSN 6505002999535 and NDC 00536-1211-95, supplied by The Harvard Drug Group, L.L.C. The solicitation number is SPE2DP-26-T-4358, with a response deadline of August 4, 2026, and the place of performance is Nellis AFB, NV. The contract includes adherence to DLA’s Master List of Technical and Quality Requirements, and buyers must submit referrals in EBS to confirm product compliance prior to award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

ALBUTEROL SULFATE INHA

Solicitation # SPE2DP-26-T-4353

Albuterol Sulfate Inhalation Aerosol with HFA is a prescription-only medication for oral inhalation, delivering 108 micrograms of albuterol sulfate per actuation, equivalent to 90 micrograms of albuterol base, supplied in an 8.5-gram canister containing 200 metered doses. The product must be stored at room temperature between 59°F and 77°F (15°C and 25°C), protected from extreme heat or cold, with specific warnings against puncturing, exposing to temperatures above 120°F, or spraying into the eyes. It has a non-extendable shelf life of 24 months and is classified as a TYPE I (CODE M) item under the Federal supply system. Labeling must include the National Stock Number, manufacturer date, expiration or retest date, contract number, and lot number, in compliance with the Medical Marking Standard No. 1, which supersedes MIL-STD-129. Packaging must meet commercial standards, with each unit sealed in a protective container and shipped in suitable exterior packaging to ensure safe delivery via common carrier. The product is regulated by the FDA and subject to Hazard Communication Standard requirements, mandating submission of Safety Data Sheets and compliant HCS labels aligned with 29 C.F.R. 1910.1200 prior to award, along with employee training on updated chemical labeling protocols. The contract specifies delivery of three units FOB destination within 20 days, with no variance allowed in quantity, and inspection and acceptance occurring at the delivery point. The NSN is 6505-01-543-6562, and the solicitation details identify Teva Pharmaceuticals USA, Inc. and Perrigo Direct Inc. as potential suppliers under procurement number SPE2DP-26-T-4353.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Same awarding agency

Small Business Subcontracting & Compliance Support

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Domestic and International Pharmaceutical Shipping & Freight Logistics

Freight Transportation Arrangement

POSTED

DEADLINE

Pharmaceutical Packaging, Labeling, and Palletization

Commercial Printing (except Screen and Books)

POSTED

DEADLINE

Hazardous Materials Compliance & Safety Data Sheet (SDS) Management

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Hazardous Materials Transportation and Delivery (FOB Destination)

General Freight Trucking, Long-Distance, Truckload

POSTED

DEADLINE

Regulated Medical Packaging and Labeling Services

POSTED

DEADLINE

Small Business Socioeconomic Certification and Compliance Support

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Specialized Medical Logistics and Transportation

Specialized Freight (except Used Goods) Trucking, Local

POSTED

DEADLINE

Hazardous Materials Compliance and Labeling Services

Other Scientific and Technical Consulting Services

POSTED

DEADLINE